<table frame="void" id="ADAE44B6-3FB7-44E3-A092-333D1F9630A8" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.</caption>
<thead>
<tr><td align="left" colspan="3" valign="top"></td></tr>
<tr><td align="left" valign="top">Population characteristics</td><td align="left" valign="top">Total body clearance* mean (range)†† (mL/kg/min)</td><td align="left" valign="top">Half-life mean (range)†† (hr)</td></tr>
</thead>
<tfoot>
<tr><td align="left" colspan="3" valign="top">For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</td></tr>
<tr><td align="left" colspan="3" valign="top">* Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute. Values listed were generally determined at serum theophylline concentrations &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics. </td></tr>
<tr><td align="left" colspan="3" valign="top">††  Reported range or estimated range (mean ± 2 SD) where actual range not reported. </td></tr>
<tr><td align="left" colspan="3" valign="top">† NR = not reported or not reported in a comparable format.</td></tr>
<tr><td align="left" colspan="3" valign="top">**  Median</td></tr>
</tfoot>
<tbody>
<tr><td align="left" colspan="3" valign="top">Age</td></tr>
<tr><td align="left" valign="top">Premature neonates  postnatal age 3-15 days  postnatal age 25-57 days</td><td align="left" valign="top">0.29 (0.09-0.49)0.64 (0.04-1.2)</td><td align="left" valign="top">30 (17-43)20 (9.4-30.6)</td></tr>
<tr><td align="left" valign="top">Term infants  postnatal age 1-2 days  postnatal age 3-30 weeks</td><td align="left" valign="top">NR†NR†</td><td align="left" valign="top">25.7 (25-26.5)11 (6-29)</td></tr>
<tr><td align="left" valign="top">Children  1-4 years  4-12 years  13-15 years  16-17 years</td><td align="left" valign="top">1.7 (0.5-2.9)1.6 (0.8-2.4)0.9 (0.48-1.3)1.4 (0.2-2.6)</td><td align="left" valign="top">3.4 (1.2-5.6)NR†NR†3.7 (1.5-5.9)</td></tr>
<tr><td align="left" valign="top">Adults (16-60 years) otherwise healthy  non-smoking asthmatics</td><td align="left" valign="top">0.65 (0.27-1.03)</td><td align="left" valign="top">8.7 (6.1-12.8)</td></tr>
<tr><td align="left" valign="top">Elderly (&gt;60 years) non-smokers with  normal cardiac, liver, and renal function</td><td align="left" valign="top">0.41 (0.21-0.61)</td><td align="left" valign="top">9.8 (1.6-18)</td></tr>
<tr><td align="left" colspan="3" valign="top"></td></tr>
<tr><td align="left" colspan="3" valign="top">Concurrent illness oraltered physiological state </td></tr>
<tr><td align="left" valign="top">Acute pulmonary edema</td><td align="left" valign="top">0.33** (0.07-2.45)</td><td align="left" valign="top">19** (3.1-82)</td></tr>
<tr><td align="left" valign="top">COPD-&gt;60 years, stable  non-smoker &gt;1 year</td><td align="left" valign="top">0.54 (0.44-0.64)</td><td align="left" valign="top">11 (9.4-12.6)</td></tr>
<tr><td align="left" valign="top">COPD with cor pulmonale</td><td align="left" valign="top">0.48 (0.08-0.88)</td><td align="left" valign="top">NR†</td></tr>
<tr><td align="left" valign="top">Cystic fibrosis (14-28 years)</td><td align="left" valign="top">1.25 (0.31-2.2)</td><td align="left" valign="top">6.0 (1.8-10.2)</td></tr>
<tr><td align="left" valign="top">Fever associated with acute viral  respiratory illness (children 9-15 years)</td><td align="left" valign="top">NR†</td><td align="left" valign="top">7.0 (1.0-13)</td></tr>
<tr><td align="left" valign="top">Liver Disease – cirrhosis                          acute hepatitis                          cholestasis</td><td align="left" valign="top">0.31** (0.1-0.7)0.35 (0.25-0.45)0.65 (0.25-1.45)</td><td align="left" valign="top">32** (10-56)19.2 (16.6-21.8)14.4 (5.7-31.8)</td></tr>
<tr><td align="left" valign="top">Pregnancy – 1st trimester                     2nd trimester                     3rd trimester</td><td align="left" valign="top">NR†NR†NR†</td><td align="left" valign="top">8.5 (3.1-13.9)8.8 (3.8-13.8)13.0 (8.4-17.6)</td></tr>
<tr><td align="left" valign="top">Sepsis with multi-organ failure</td><td align="left" valign="top">0.47 (0.19-1.9)</td><td align="left" valign="top">18.8 (6.3-24.1)</td></tr>
<tr><td align="left" valign="top">Thyroid disease - hypothyroid                             hyperthyroid</td><td align="left" valign="top">0.38 (0.13-0.57)0.8 (0.68-0.97)</td><td align="left" valign="top">11.6 (8.2-25)4.5 (3.7-5.6)</td></tr>
</tbody>
</table>